Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

GenomOncology To Enable CompanionDxTM Clinical Cancer Panels

Published: Monday, February 10, 2014
Last Updated: Monday, February 10, 2014
Bookmark and Share
The GO Clinical WorkbenchTM is selected to launch a series of next generation sequencing (NGS)-based assays.

GenomOncology announced today that CompanionDxTM has selected the company’s GO Clinical WorkbenchTM to launch a series of next generation sequencing (NGS)-based assays related to cancer. CompanionDxTM will leverage GenomOncology’s GO Clinical Workbench to manage the entire workflow: from raw sequencing data through delivery of an actionable clinical report to the client.

CompanionDx™ is a provider of both personalized pharmacogenomics evaluations and cancer companion diagnostic testing. When used separately or in conjunction, these two types of tests give physicians the resources necessary to develop comprehensive patient treatment profiles, thereby creating more certainty in therapeutic decisions.

David Lasecki, President of CompanionDxTM, commented “As we develop new tests that leverage next generation sequencing, we require a solution that meets our current needs but is scalable over time. GenomOncology’s platform and services will allow us to efficiently add new cancer panels and expand our testing options to best serve our clients.”

The GO Clinical Workbench provides the laboratory with a fully traceable analysis workflow and rules-based decision support tool for the clinical interpretation of somatic mutations.  

“Providing the oncologist with actionable data that is specific to a patient’s tumor in days instead of weeks adds to the medical utility of next generation sequencing,” added Manuel Glynias, President and CEO of GenomOncology. “The convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to improve clinical outcomes for many patients with cancer.”

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Illumina Contributes to ClinVar Database
The contribution includes variants of all classifications, from pathogenic to benign, identified during interpretation of whole genome sequences generated in the CLIA-certified, CAP-accredited Illumina Clinical Services Laboratory.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.
Inflammation Test May Predict Cardiovascular Disease
An assessment combining measures of immune-cell responsiveness predicted cardiovascular problems in individuals who likely would have slipped under the radar.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Potential Urine Test for CJD
Researchers at the Medical Research Council (MRC) Prion Unit at UCL have found that it may be possible to determine whether or not a person has sporadic Creutzfeldt-Jakob Disease (sCJD) by testing their urine for the presence of abnormal prion proteins.
ReadCoor Launched to Commercialize 3D Sequencing Tech
ReadCoor will leverage the Wyss Institute’s method for simultaneously sequencing and mapping RNAs within cells and tissues to advance development of diagnostics.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos